On the contrary, analyses conducted by real-time PCR on tissue microarrays showed no change in IGF-I or IGF-II transcripts between normal glial samples and high-grade gliomas, including GBMs (23, 25). The gene discussed is IGF2; the disease is central nervous system cancer.